In this review we present a concept that, despite mounting evidence, received little attention so far: susceptibility to adult neurodegenerative diseases may be programmed in utero and early postnatal preventive measures may reduce the risk. We delineate the key mechanisms and players mediating this phenomenon laying a foundation for preventive strategies. First, we discuss what is likely the most common insult taking place during fetal development and imprinting upon fetal brain: chronic pregnancy stress. We propose that such imprinting is mediated via the microglial (and perhaps astrocytic) memory and that such memory may increase susceptibility to neurodegenerative diseases in adult life. We discuss microglial plasticity and mechanisms by which in utero insults influence the dynamic process of microglialneuronal interactions in the developing brain. Microglial role in adult neurodegenerative disorders is reviewed and this concept is brought back to the perinatal origins of adult susceptibility to neurodegeneration. We review epigenetic mechanisms which may yield early biomarkers. Can we devise novel early life modifying interventions to steer developmental trajectories to their optimum?
Introduction
In this focused review, we present a concept that, despite mounting evidence, received little attention so far: susceptibility to adult neurodegenerative diseases may be programmed in the womb and early postnatal preventive measures may reduce the risk. We delineate the key mechanisms and players mediating this phenomenon, foundation for preventive strategies. First, we discuss what is likely the most common insult taking place during fetal development and imprinting upon fetal brain: chronic pregnancy stress. We propose that such imprinting is mediated via the microglial (Barros, Duhalde-Vega, Caltana, Brusco, & Antonelli, 2006) memory and that such memory may increase susceptibility to neurodegenerative diseases in adult life. This concept requires a discussion of microglial plasticity and mechanisms by which in utero insults influence the dynamic process of microglial-neuronal interactions in the developing brain. A very specific signaling mechanism has come into light that promises to play a role not only in understanding the mechanisms of such glial memory formation, but also in devising novel modifying treatments to steer developmental trajectories to their optimum, the ultimate dream of perinatal neuroscience. Studying and testing such mechanisms requires animal models which we review, briefly. Finally, microglial role in adult neurodegenerative disorders is discussed and this concept is brought back to the perinatal origins of adult susceptibility to neurodegeneration. Intuitively, epigenetic mechanisms take a center stage throughout the review.
Brain memory of stress during fetal development: the concept
The complex development of the nervous system is characterized by essential processes like cell proliferation, migration and differentiation that follow a tightly regulated program at well-coordinated time points to ensure the establishment of brain structures and functions (Andersen, 2003) . During this developmental process the organisms may be exposed to insults and environmental influences that might be critical for later susceptibility to diseases. Several models have been proposed to explain how exposure to insults during in utero and/or early postnatal stages affects the development of target organs, disrupting homeostasis and increasing the risk for diseases manifested later in life. Based on their studies on adult cardiovascular diseases, Barker proposed the hypothesis of the Fetal Basis of Adult Diseases (FeBAD) . FeBAD suggests that the fetus responds to the maternal health status behaving as a maternal "radar" and mounting adaptive responses for survival.
According to the Predictive Adaptive Response (PAR) model of Gluckman and Hanson (2006) , the fetus predicts the extra-uterine environment by sensing the intrauterine conditions and adapts to improve survival. Later, Gluckman extended this concept introducing the most cited model of Developmental Origin of Health and Disease (DOHaD) that postulates that the postnatal period of development also plays a role in health (Gluckman, Hanson, & Mitchell, 2010) . Ben-Ari suggests that neurological disorders might be, in part, born at early developmental stages before symptoms appear (Ben-Ari, 2008) , prompting Van den Bergh to formulate the hypothesis of the "Developmental Origins of Behavior, Health and Disease" (DOBHaD), which integrates early brain and behavioral development with new insights from the field of epigenetics (B. R. Van den Bergh, 2011) . Van den Bergh proposes that rather than treating symptoms after disease is manifested, initial non-invasive recording of disease signatures may guide the understanding of the pathology enabling early diagnosis and potentially improving treatments. These notions thus introduce the crucial concept of prevention of diseases before they start to develop. Lahiri also emphasizes on the role of epigenetics in early life by introducing the term "hit" to denote the early environmental exposure acting through the induction of latent epigenetic changes. Accumulation of a "n" number of hits along the life of an individual eventually triggers disease (Lahiri, Maloney, & Zawia, 2009 ). Furthermore, Hertzman suggests that early child development is influenced by the psychosocial environment of the child that adds up to the health status during adulthood (Hertzman, 1999) . More recently, this process has been named "biological embedding" and includes the epigenetic changes that occur early in life and affect behavior and physiology (Danese & McEwen, 2012; McEwen, 2016) .
In summary, these models point to the concept that adult health and behavior are programmed in utero, continue to be shaped postnatally experiencing ongoing modifications by new exposures mediated by epigenetic changes.
Perinatal stress is a well-studied, powerful driver and modulator of an individual's spatiotemporal epigenetic landscape: different cell types and organs, the brain's in particular, respond differently to stress at different developmental time points due to genomic-/epigenomic-environmental interactions (Conradt et al., 2018; M. G. Frasch, Lobmaier, et al., 2018; Metz, Ng, Kovalchuk, & Olson, 2015) . Much of this body of evidence has been gathered in animal studies (M. G. Frasch, Baier, Antonelli, & Metz, 2018) . We believe that animal models will continue to be indispensable for studies of glialneuronal development under various insults, such as perinatal stress, to understand their mechanistic contribution to developmental programming of increased susceptibility to neurodegenerative diseases. We review some of the pertinent animal model paradigms in the following section.
Animal models of perinatal stress reveal links to early life neuroinflammation and neurodegeneration
The last twenty years have witnessed an exponential increase in publications related to the effect of perinatal stress on offspring neurodevelopment both in animal models and in humans (M. G. Frasch, Baier, et al., 2018; Jawahar, Murgatroyd, Harrison, & Baune, 2015; B. R. H. Van den Bergh et al., 2017) . When referring to Perinatal Stress a distinction has to be made between models of Prenatal Stress (Hubacek et al., 2000) and Postnatal Stress, the latter often referred to as Early Life Stress (ELS).
Animal models of Prenatal stress:
PS protocols have been designed to transfer the stress experience of the mother to the embryo in utero by exposing the pregnant dam to stressors during different gestational phases. Several species have been employed and although most have been conducted in rats and mice, Rhesus macaques, guinea pigs and sheep have also been used. Accounting for the different lengths of gestations among different species, most protocols differ in the type of applied stressor, daily frequency, length of application and week of gestation chosen.
Several paradigms have been employed in the different species, but they can be primarily divided into: a) predictable stressor (same stressor along several days) or b) unpredictable stressor (aleatory variable stress). Stressors applied range from restraint, saline injections, overcrowding, hypoxia, exposure to a cold environment, REM sleep deprivation, swim stress, electric foot shock, food deprivation or exposure to loud noise (Bock, Wainstock, Braun, & Segal, 2015; Huizink, Mulder, & Buitelaar, 2004; Mastorci et al., 2009 ).
Animal models of Early Life Stress:
Stress experienced during the early postnatal period (first weeks of development after birth) has been repeatedly shown to cause long-lasting changes in behavior, cognition and physiology both in humans and animals. Preclinical studies have been performed in several species ranging from mammals, to non-mammals and even invertebrates (Chaby, 2016) . We will briefly summarize here the type of stressor and the timing of ELS in mammal models. The most common paradigms and timing of ELS reported are: handling (brief daily separation of pups from mother between postnatal day (PND) 1-21); maternal separation (longer daily separation of pups from mother between PND 1-21); maternal deprivation (single episode of separation of pups as a litter from mother for 24 h, usually on PND 3 or 9); early weaning (weaning of pups between PND14 and PND21); low vs high LG-ABN (licking grooming arched-back nursing: pups raised by biological mothers who were previously divided into high or low caregivers) (Jawahar et al., 2015; McDonnell-Dowling & Miczek, 2018) .
Researchers describe a "two-hits" hypothesis for neurodegenerative diseases such as Parkinson's or Alzheimer's disease (PD, AD), in which the first potential impact occurs early in life (Faa et al., 2014) .
Prenatally stressed ("first hit") adult rats exposed to a "second hit", an intrastriatal injection of 6-hydroxy-DA (6-OHDA) (a traditional method to produce neurodegeneration in DA neurons) showed higher levels of cells expressing tyrosine hydroxylase (TH) in the ventral tegmental area (VTA) and that these cells were more susceptible to a neurochemical insult with (6-OHDA). In addition, the number and asymmetry of neuronal nitric oxide synthase-expressing cells in the VTA and nucleus accumbens were different in PS rats. These results suggest a deregulation between dopaminergic and nitrergic system in the VTA of PS rats, which responded to the neurotoxic aggression by increasing the number of nNOS cells, whose function might be involved in the neuroprotection of TH cells (Baier et al., 2014) .
At present, unquestionable evidence from animal research shows that exposure to an insult during the prenatal period or during early postnatal life development may lead to a reprogramming of tissue structure and function, turning the offspring vulnerable to later learning and cognitive delays, cardio metabolic and neuroendocrine impairment among other diseases (B. R. Van den Bergh, 2011 ). At the brain tissue level, both neuronal and glial cells have been shown to be critically impaired not only at the morphological level but at the level of the associated neurotransmitter systems as well. We have shown that adult male offspring of stressed dams exhibited a long-lasting astroglial reaction with reduced dendritic arborization (Barros et al., 2006) . Concomitantly, we observed an increase of ionotropic and metabotropic glutamate receptors in frontal cortex (FCx), striatum and hippocampus (Berger, Barros, Sarchi, Tarazi, & Antonelli, 2002) with elevated levels of vesicular vGluT-1transporter in the FCx and GLT1 in hippocampus in parallel with increased uptake capacity for glutamate in the FCx as well as changes in the nitric oxide synthase-expressing cells (Baier et al., 2014) .
Other authors also reported that PS produces changes in the glutamatergic metabolism in terms of a hypofunction of glutamatergic neurotransmission in the ventral hippocampus (Marrocco et al., 2012) , elevated glutamate receptors expression in a sexdependent manner (Y. Wang et al., 2016; Zuena et al., 2008) as well as an enhanced expression of microglial activation markers (Slusarczyk et al., 2015) , increases in the number of microglial cells with large somas (Diz-Chaves, Pernia, Carrero, & GarciaSegura, 2012) and an acceleration of microglial differentiation into a ramified form in the pre-weaning offspring (Gomez-Gonzalez & Escobar, 2010) .
It is well known that excessive activation of ionotropic glutamate receptors causes excitotoxicity and promotes cell death, underlying a potential mechanism of neurodegeneration. In addition to the excitotoxicity and inflammatory processes that characterize neurodegenerative disorders, an emergent role has recently been discussed for the nitric oxide pathways in relation to the glutamate neurotoxicity (Manucha, 2017) . Glutamate receptors are also expressed in microglia and it has been postulated that a dysfunction of the subunit GluA2 may accelerate Glu neurotoxicity via release of proinflammatory cytokines from microglia in neurodegenerative diseases (Noda, 2016) .
Over-activation of microglia due to PS may inflict changes in adulthood. PS paradigms such as models of depression affect the offspring later in life, inducing behavioral changes in adult mice and elevated release of chemokines and profuse microglia activation (Slusarczyk et al., 2015) . Recent studies also indicate the role of inflammation in microglial type and behavior in aging offspring of stressed mothers. Early life exposure to lipopolysaccharides (LPS) results in differential location of activated microglia in the brain accompanied by sustained alterations in the hippocampal microglia that become hypersensitive to inflammatory markers. These changes endure throughout adulthood and have negative effects on memory and learning (Schaafsma et al., 2017) .
In light of the reviewed evidence in animal models of ELS for the significant reprogramming of the glutamatergic-nitric oxide-microglia metabolism observed in the prenatally stressed offspring, it is plausible to expect that insults received during the prenatal and/or early life period increase brain's susceptibility to neurodegenerative diseases in later life.
Microglial plasticity
The notion of brain's memory is usually linked to the concept of neuronal plasticity, i.e., the ability of neuronal cells and neuronal enables to adapt to their environment, individually and collectively. Evidence is mounting that similar mechanisms operate in glial cells, particularly microglia. Beyond their role as the "conventional macrophages of the brain," microglia have fundamental roles in developing and shaping synaptogenesis. Alterations of glial-neuronal interactions have recently been recognized as important players in early stages of Alzheimer's and other adult neurodegenerative diseases (Bilbo & Stevens, 2017; Madhusudan, Vogel, & Knuesel, 2013) .
While this review focuses on microglia, we are compelled to remember that a full understanding of brain programming predisposing to neurodegenerative diseases will require incorporation of astrocytes and oligodendroglia and their dynamic interactions with microglia and neuronal cells (Dutta et al., 2018; Hong et al., 2016; Liddelow et al., 2017) .
Fetal and neonatal insults programming microglial memory
Fetal microglia and astrocytes exhibit memory of preceding insults . Does such plasticity come at a cost of a reduced reserve for future hits? Does such reduced reserve translate into an increased susceptibility to adult neurodegenerative diseases (Paolicelli et al., 2011) ? Pioneering work by Ben Barres and Beth Stevens labs highlighted the role of the complement pathway in the microglial-neuronal interactions which over time indeed make the brain more vulnerable to Alzheimer's development (Hong et al., 2016; Schafer et al., 2012) .
We observed that similar signaling pathways and, the iron homeostasis pathway in particular, mediate microglial memory of in utero insults, even when the adverse event is clinically asymptomatic (Cortes et al., 2017) . Interestingly, these findings suggest that the α7nAChR signaling in microglia is involved in the early programming of susceptibility to AD. That means that cognitive dysfunction may result not only from iron overload, but also from derangements in the neuronal-glial complement pathway interactions. Hyperactive microglia may prevent physiological synaptogenesis predisposing to AD later in life (Hong et al., 2016; Stephan, Barres, & Stevens, 2012) . The mediating pathway involves microglial-neuronal complement signaling suggesting that microglia could be early therapeutic targets for AD prevention or treatment. Targeting microglia may also be therapeutically relevant to other neurodegenerative diseases. The complement genes C1Q and CR3 (also known as CD11B) were involved in the microglia-mediated synaptic loss in a mouse model of AD (Hong et al., 2016) . Less is known about the function of the complement receptor 2 (CR2, also known as CD21) in neuroinflammation, especially in microglia. One study reports CR2−/− mice to be more prone to neuronal injury with higher levels of astrocytosis following nerve root cord injury. This would suggest a neuroprotective role for CR2 (Lindblom et al., 2015) . Another study reports CR2−/− mice subjected to traumatic brain injury to exhibit less astrocytosis and less microglial activation which would suggest the opposite role for CR2 (Neher et al., 2014) . In mice, CR1 and CR2 are coded on the same gene and expressed as splice variants. In sheep, however, and other higher mammals these complement genes are coded separately. Hence, more studies are needed to gauge the functional role of CR2 in neuroinflammation, microglia in particular, especially with respect to human neurodegenerative diseases such as Alzheimer's. In primary fetal ovine microglia cultures, we found that agonistic stimulation of the α7 nicotinic acetylcholine receptor (α7nAChR) up-regulated C3AR1 when compared to blocking the receptor. We believe these findings deserve further study because pro-cholinergic drugs are used to treat Alzheimer's symptoms, but the consequences of cholinergic stimulation on microglial signaling are not well understood. Our results suggest that blocking rather than enhancing α7nAChR signaling in microglia may be beneficial to help slow down synaptic degradation.
Returning to the role of PS in the predisposition to neurodegenerative diseases, there is evidence linking α7nAChR expression in the brain with PS. We analyzed the consequences of PS on gene and protein expression of nAChRs in the brain of the adult male offspring . Our results demonstrate that prenatal exposure to maternal restraint stress reduced protein expression of α7nAChRin the frontal cortex and hippocampus, key areas of AD pathology, in adulthood. We demonstrated that PS has long lasting consequences in the pattern of nAChR expression in the brain of prenatally stressed rat offspring. Further studies are needed to link cell type -specific expression of α7nAChR to PS as well to neuropathological and behavioral phenotypes in mid and late adulthood.
Role of Microglia in Adult Neurodegenerative disorders: early life origins
Inflammation is a prominent axis of neuropathology common to most neurodegenerative disorders in adulthood. While the role of inflammation as cause or consequence of neuronal death is still under debate, the involvement of alterations in microglia in the pathophysiology of neurodegeneration is indisputable. We first review briefly the "adult" pathophysiology linking neurodegeneration with neuroinflammation, focusing on AD and PD. We then proceed to reviewing the evidence expanding this connection to the early life exposures.
Alzheimer's disease and neuroinflammation
AD is a multifactorial neurodegenerative disorder that affects more than 5 million Americans over the age of 60 and represents the most prevalent form of dementia in older adults. AD is manifested clinically by progressive memory loss and a gradual decline in global cognitive function interfering with daily living (Querfurth & LaFerla, 2010) . At the pathological level, AD is characterized by accumulation of amyloid- (A) in amyloid plaques (Glenner & Wong, 2012) and phosphorylated Tau protein in neurofibrillary tangles (Grundke-Iqbal et al., 1986) , resulting on neuronal loss in the neocortex and the hippocampus.
Inflammation has been implicated in the neuropathological cascade leading to the development of A neuritic plaques (Gorelick, 2010) contributing to dementia and cognitive impairment in the elderly. Cytokines, chemokines and complement factors are found in the cerebrospinal fluid and in A plaques of AD patients, and several epidemiological studies and clinical trials link inflammatory markers to dementia and cognitive impairment (Aisen et al., 2003; Barber, 2011; Beard, Waring, O'Brien, Kurland, & Kokmen, 1998) .
Transcriptomic analysis of postmortem brain samples from AD cases showed a tight correlation between the increased expression of genes related to chronic neuroinflammation, including IL-1β, IL-10, IL-6 and IL-8, with markers for macrophages and apoptosis, suggesting that aberrant inflammatory response is linked to gene expression deregulation (Day & Sweatt, 2010) . Importantly, altered expression of inflammationrelated genes is evident at early stages of pathology even before the onset of cognitive decline, highlighting the role of microglia impairment and the inflammatory cascade in the progression of AD pathology (Jain, 2010) .
Microglia have important roles in shaping synapses and as resident macrophages (Day & Sweatt, 2010) involved in immune surveillance in the central nervous system, including phagocytosis and disposal of misfolded protein aggregates, which accumulate at a higher rate in the aged brain. Aging and degeneration diminish microglia function, as evidenced by disruption of specific microglia transcripts such as TREM2 and CD33 (Clayton, Van Enoo, & Ikezu, 2017) . Interaction of microglia with A plaques stimulates the activation of the pro-phagocytic M2 phenotype to clear A ; however, as the plaque burden increases in the brain overtime, microglia exhibit more frequently the proinflammatory M1 phenotype (Tang & Le, 2016) , generating a neuroinflammatory environment that fails to be resolved in the AD brain and propels neuronal death. In particular, A fragments 1-42, that seed aggregation and plaque formation, interact with the TLR2 receptors inducing M2 microglia and triggering a neurotoxic response (S. Liu et al., 2012) . A single exposure to A induces the transcription of pro-inflammatory molecules iNOS and TNF in microglia (Heurtaux et al., 2010) . Persistent activation of the tyrosine kinase pathway due to A oligomers eventually results in the release of neurotoxic factors (Dhawan, Floden, & Combs, 2012) ; upregulation of TNF production and concomitant increase of IL-1 or IL-6 cytokines (Meda et al., 1995) . On the other hand, amyloid- stimulated microglia show high levels of phagocytic markers such as AXL, CLEC7A, LGALS3, CD11C, TREM2, and TYROBP that may trigger an the hyperactive response which has been reported specifically in patients with early onset AD (Yin et al., 2017) .
Bringing this brief review of AD etiology back to ELS and microglial memory, there is evidence linking chronic stress with AD and implicating microglia-mediated synaptic remodeling and inflammation in early pathophysiology of AD (Bisht, Sharma, & Tremblay, 2018; Cook & Wellman, 2004; Juster, McEwen, & Lupien, 2010; Magarinos, Verdugo, & McEwen, 1997) . Studies are needed now to extend these findings into early life period in the sense of the early microglial programming paradigm we propose in this present review. The presence, brain regional distribution and role of the dark microglia, diseaseassociated microglia or microglia with a neurodegenerative phenotype in the developing stressed brain should be validated in fetal and early postnatal periods of stress exposures (Bisht et al., 2018) . Can the phenotype of such pathological microglia, in particular the stress-induced expression of CD33, which reduces microglial Aβ phagocytosis, be reversed by early life interventions? We return to this question in Section 8.
Parkinson's disease and neuroinflammation
PD is the second most frequent neurodegenerative disorder of the elderly, characterized clinically by motor impairment, gait disturbance, tremor, gastrointestinal dysfunction; REM-sleep disturbance and cognitive impairment. At the pathological level PD is characterized by accumulation of aggregates of -synuclein protein (-syn) in Lewy body structures mainly in the substantia nigra (SN), and by loss of dopaminergic neurons (Burn, 2006; Spillantini et al., 1997; Takeda et al., 1998) . PD is a multifactorial disorder where genetic and environmental factors converge to generate pathology, and more than 90% of cases are of sporadic origin. Emerging data supports that chronic neuroinflammation is highly prevalent in PD, and increased number of microglia and microgliosis have been reported in postmortem PD brains (Doorn et al., 2014) and transgenic animal models of PD (Watson et al., 2012) . Importantly, microgliosis is more evident in the vicinity of dopaminergic neurons that are primed to degeneration, including SN, hippocampus and cortex, areas that show high rates of neuronal loss in PD (Banati, Daniel, & Blunt, 1998; Imamura et al., 2003; McGeer, Itagaki, Boyes, & McGeer, 1988; Sawada, Imamura, & Nagatsu, 2006) . Studies suggested that increased levels of proinflammatory molecules like TNF, IL6, nitric oxide synthase (Fernandez-Lizarbe, Montesinos, & Guerri, 2013) and cyclooxygenase-2 (COX-2) produced locally by activated microglia contributes to the cell-specific vulnerability observed in PD (Block, Zecca, & Hong, 2007; Dufek, Rektorova, Thon, Lokaj, & Rektor, 2015; Hunot et al., 1996; Knott, Stern, & Wilkin, 2000) . For example, in the mouse brain, nigral neurons are more vulnerable to the pro-inflammatory bacterial lipopolysaccharide than cells in the cortex or hippocampus; an effect mediated by the higher density of activated microglia observed in the SN in comparison to other brain nuclei (W. G. Kim et al., 2000) .
On the other hand, exacerbated neuronal death can trigger microglial activation, feeding in a deleterious feedback loop. Substances which are produced by dying dopaminergic neurons and which can activate microglia include: α-synuclein aggregates (W. Zhang et al., 2005) , ATP (Davalos et al., 2005) , MMP-3 (Y. S. Kim et al., 2007 ; Y. S. Kim et al., 2005) and neuromelanin (Wilms et al., 2003) . Notably, suppression of microglial activation alleviates PD phenotype in mouse models, further supporting the role of these cells in the pathophysiology of PD (Wu et al., 2002) .
In case of PD, chronic stress, once again, is emerging as a serious risk contributor. In the recent study of ~2,5 million Swedes finding themselves in job environments resulting in chronic stress, such exposure was associated with increased risk of PD (Sieurin et al., 2018) .
Innate immune system, inflammation and Alzheimer's disease
As mentioned earlier, PD and AD share neuropathological mechanisms including inflammation; therefore, it is not surprising that prenatal challenging of the murine immune system has also been associated with neuroinflammation and AD-like lesions in the adult brain of exposed organisms. For example, prenatally challenging the immune system of mice by exposure to Poly I:C (polyriboinosinic-polyribocytidilic acid) during gestation results in chronic elevation of inflammatory cytokines, higher levels of amyloid precursor protein (Kazlauskas, Campolongo, Lucchina, Zappala, & Depino, 2016) in the hippocampus, increased Tau phosphorylation and defective working memory in old age animals highly resembling AD pathological features. These alterations are accompanied by microglial activation and reactive gliosis, once more suggesting that priming the microglial system during early life favors a chronic inflammatory state that seeds neurodegenerative changes in the adult (Krstic et al., 2012) .
In the scenario that neuroinflammation precedes neuropathology in AD, a crucial question is what triggers this process and how inflammation reaches the brain. One plausible explanation is that AD is more a systemic disease rather than a brain-restricted disorder. The innate immune response system eliminates pathogens in a fast and nonspecific reaction involving inflammation. In the periphery, this system is composed by neutrophils, monocytes/macrophages, dendritic cells and natural killer cells, while in the brain this function is fulfilled by resident microglia (Le Page et al., 2018) . Recently, the role of the innate immune system in the pathophysiology of AD has gained attention after genome-wide association studies (GWAS) identified clusters of alleles involved in innate response that confer higher risk for AD (Crotti & Ransohoff, 2016; Guillot-Sestier, Doty, & Town, 2015) .
Adaptive immunity however, cannot be initiated directly in the brain. Once microglia are activated in response to an insult, secretion of cytokines and chemokines is increased, attracting circulating lymphoid and myeloid cells and thus establishing a communication between the brain and the systemic immune response mechanisms (Ransohoff & Brown, 2012) . In addition, alterations in the brain blood barrier observed in most neurodegenerative diseases, facilitate the flow of inflammation-related molecules between the brain and the systemic circulation, enabling the cross-talk between these systems (Busse et al., 2017) . Therefore, adverse events during early life may affect the communication between brain and periphery paving the road for inflammatory-initiated diseases during adulthood.
Prenatal infections and Parkinson's disease
Multiple environmental toxins, particularly agrichemicals, have been linked to increased risk for PD (Desplats et al., 2012; A. Wang et al., 2011) , and in many cases inflammation seems to be the underlying mechanism. The effect of an environmental exposure can be manifested many years later in life, and indeed, emerging evidence suggest that infections during the prenatal life impact the susceptibility to PD (Collins, Toulouse, Connor, & Nolan, 2012) . Maternal infections like bacterial vaginosis may potentially increase the risk of the neonate to develop PD, an effect apparently mediated by the rise in chorioamniotic LPS and TNF-α levels in infected pregnant women (Z. Ling et al., 2002; Menon, Guy, & Tan, 1995; Okada et al., 1997) , which may hinder typical dopaminergic neuronal development as evidenced by animal studies in vitro and in vivo.
Similarly, prenatal exposure to LPS increases the vulnerability of rats to rotenone later in life, resulting in synergistic effects that increase loss of tyrosine-hydroxylase (TH) cells in the SN in comparison to LPS-naïve animals. Dopaminergic cell loss was associated with increased levels of TNF-α and reactive microglia (Z. D. Ling et al., 2004) . Other studies also support the idea that viral infections in the prenatal environment can also prime the organism increasing their risk to develop PD as adults; an effect that is potentially mediated by changes in density and/or activation states of microglia. In utero exposure to the synthetic dsRNA analogue Poly I:C to simulate a viral infection, increases the production of pro-inflammatory cytokines in the brain of exposed rats (Cunningham, Campion, Teeling, Felton, & Perry, 2007) . Importantly, these events aggravate neurodegeneration (Field, Campion, Warren, Murray, & Cunningham, 2010) , inducing severe decay of the nigrostriatal dopaminergic system in adult animals (Deleidi, Hallett, Koprich, Chung, & Isacson, 2010) . While the specific role of microglia in mediating prenatal infections, dopaminergic neuronal loss and PD risk is yet to be defined, taken together, these studies point at inflammation as the link between prenatal stress and PD risk.
Epigenetic mechanisms link prenatal adverse environment, microglial activation and adult neurodegenerative disorders.
Epigenetic mechanisms, including DNA methylation, post-transcriptional histone modification and microRNA signaling networks directly modulate gene expression and are dynamically regulated in post-mitotic neurons, with crucial functions in memory formation and synaptic plasticity, modified by chronic stress exposure for example (Day & Sweatt, 2010; Herrera et al., 2015; Shaltiel et al., 2013) . Mounting evidence now demonstrates that alteration of epigenetic regulation is deeply linked to neurodegeneration and potentially playing a role in the pathophysiology of neurodegenerative disorders. For example, AD brains show a general decay in global methylation and an acceleration of aging as measured by methylation markers (Levine, Lu, Bennett, & Horvath, 2015; Urdinguio, Sanchez-Mut, & Esteller, 2009) , particularly in areas selectively vulnerable to pathology (Mastroeni et al., 2010) . In PD brains, we observed aberrant localization of DNA methyl transferase 1 (DNMT1) which is retained in the cytoplasm of neurons due to interaction with aggregated -syn and resulting in reduced methylation of genes associated with PD pathology (Desplats et al., 2011) .
Notably, epigenome-wide association studies in cognitively impaired subjects and AD cases identified significant changes in DNA methylation at 71 methylation sites across the genome, that were associated with the burden of AD pathology. Among the differentially methylated genes, ANK1 and RHBDF2 are involved in the signaling cascade that modulates the activation of microglia and infiltrating macrophages to release TNFα from the cell surface (De Jager et al., 2014) . More recently, ANK1 was reported to be specifically upregulated in microglia isolated from the hippocampus of AD brains, without significant changes detected in neurons or astrocytes from the same samples (Mastroeni et al., 2018) . Therefore, methylation changes associated with AD pathology appear to directly regulate the activation of microglia and to play important roles in neuroinflammation.
Similarly, screening of chromatin state dynamics in the hippocampus of an inducible mouse model of AD showed upregulation of immune response genes and regulatory regions, with enrichment for target regions of the ETS family of transcriptional regulators, like PU.1, implicated in activation of macrophages, and pointing again at microglia-specific activation as a contributor to transcriptomic alterations. When mapped to orthologous regions in the human genome, the enhancers activated in mice corresponded to immune cell expression quantitative trait loci, further implicating immune processes in AD predisposition, and the involvement of chromatin remodeling in triggering inflammatory responses (Gjoneska et al., 2015) .
Recently, another microglial factor, TREM2, has been the focus of attention in AD research, after the identification of genetic variants in this gene that increase the risk to AD (Jin et al., 2014) . TREM2 is expressed by activated microglia and the specific transcriptomic changes associated with neurodegeneration also involve the apolipoprotein E (APOE), whose allelic variants represent the highest genetic risk for AD (Michaelson, 2014) . TREM2 gene present differential methylation in AD brains (Smith et al., 2016) , supporting a role for the epigenetic machinery in the modulation of the microglial transcriptome that may cause neurodegeneration. Importantly, expression of APOE induced by microglia during early development may prime microglial gene expression towards the profiles associated with neurodegeneration (Krasemann et al., 2017) . Key genes at almost every level of the inflammatory cascade appear to be regulated by DNA methylation, and CpG-rich sites-targets for methylation in the DNA have been identified at regulatory regions of IL-2 (Bruniquel & Schwartz, 2003; Murayama et al., 2006) , CXCL2 (Fischer, Onur, Schmelzer, & Doring, 2012) , chemokine receptors CXCR4 (Ramos et al., 2011) , and CCR7 (Mori et al., 2005) . The production of proinflammatory cytokines IL-1β and TNF-α appears to be regulated by redox-dependent and epigenetic and mechanisms as well (Wessels, Haase, Engelhardt, Rink, & Uciechowski, 2013) . Moreover, the regulation of IL-6 requires the cross-talk between different epigenetic players including TET2 to regulate DNA methylation and HDAC2 to modulate histone acetylation, a process that reduces inflammation by repression of IL-6 in macrophages (Q. Zhang et al., 2015) .
Epigenetic transitions play a role in microglial activation. In mouse models of traumatic brain injury a sub-population of reactive microglia presents a distinct epigenetic signature characterized by global decreased methylation (Z. Y. Zhang, Zhang, Fauser, & Schluesener, 2007) . Thus, chromatin remodeling appears to be a necessary step in the initiation of the inflammatory cascade in the brain.
Research indicates that microglia activation may also be dependent on histone modifications. Suh et al. illustrated the role of histone changes on microglia activation by showing that treatment with histone deacetylase inhibitors (HDACi) decreases the release of cytokines, including TNFα, IL-10, IL-1α and IL-6; hence suggesting that histone modifications may repress immune responses (Suh, Choi, Khattar, Choi, & Lee, 2010) . More recently, using a mouse model where knock down of Hdac1 and Hdac2 was specifically directed to microglia, Datta et al. demonstrated that while these enzymes are not required for the survival of adult microglia in the normal brain; deletion of Hdac1 and Hdac2 in the context of AD pathology increases the phagocytic activity of microglia, reducing amyloid plaques and cognitive decline (Datta et al., 2018) .
Datta et al. also investigated the effects of prenatal ablation of HDACs, taking advantage of their inducible model. Interestingly, the lack of these histone-modifying enzymes resulted in alterations in microglia proliferation and increased apoptosis, likely due to activation of cell death-signaling pathways induced by higher levels of histone acetylation (Datta et al., 2018) . In a similar context, prenatal exposure to HDACi valproic acid results in higher density of microglia as well as modification of histones, further suggesting that modulation of histone modifications directly affects microglia abundance (Kazlauskas et al., 2016) . This epigenetic cascade seems to propagate across CNS celltypes: activated microglia induces histone deacetylation in astrocytes, reducing GSH (glutathione) transcription (Correa, Mallard, Nilsson, & Sandberg, 2011) . Low levels of GSH, in turn, trigger inflammatory molecules such as TNF-α, IL-6 and also stimulate kinase pathways further exacerbating the inflammatory state in neurodegenerative disorders Pocernich & Butterfield, 2012) .
A more recent study added evidence to the notion that immune memory in macrophages is executed by epigenetic alterations; showing that changes in histone methylation (H3K4me1) and acetylation (H3K27ac) associate with activation of enhancers that modulate inflammation-related genes. Furthermore, Wendeln et al. demonstrated that peripheral inflammation induce epigenetic remodeling in brain-resident macrophages which become tolerant to further inflammatory stimuli for at least 6-months, a phenomenon that alleviates amyloidosis in a mouse model of AD (Wendeln et al., 2018) .
Finally, the function of microRNAs in shaping microglial-neuronal communication represent another regulatory mechanism that is just been unraveled. Due to the pleiotropic effects of microRNAs in the transcriptome, the effects of early-life programming of these pathways remain to be understood (Shaltiel et al., 2013; Soreq & Wolf, 2011) .
Epigenetic mechanisms also mediate the effects of maternal behavior during early life in modulating microglial responses in the brain. Increased maternal care reduces methylation at the IL-10 promoter specifically in microglia in a model of drug addiction in rats, and results in higher expression of IL-10 in early in life. Elevated IL-10 is sustained throughout adulthood in the nucleus accumbens and results in inhibition of microglial reactivity after drug exposure, a cycle that prevents reinstatement of morphine addiction in adult animals (Schwarz, Hutchinson, & Bilbo, 2011) . While this study was focused on a different paradigm, it provides another example on how epigenetic remodeling is a likelihood mediator of early life experience that can modulate microglial responses and disease risk later in life. Future studies in animal models and human cohorts could attempt to infer from these known epigenetic mechanisms panels of early biomarkers of increased susceptibility for neurodegenerative diseases in adult life.
Can early-life programing be reversed?
There is a major, translationally relevant silver lining to this seemingly fatalistic view at in utero programming of neurodegenerative disorders in adult life. While an adverse prenatal environment seems to increase the risk for neurodegeneration later in life, exposure to an enriched environment (EE) during early life may reduce the odds of neurodegeneration; a mechanism also mediated by microglia. EE is known to induce neurogenesis (Clemenson et al., 2015) , and some studies suggest that EE can impact the number of microglia in cortex and hippocampus and their inflammatory and phagocytic activity (Williamson, Chao, & Bilbo, 2012) . A recent study also showed that EE can modulate microglia in the dentate gyrus, resulting in a lower inflammatory response of microglia after exposure to A oligomers (Xu et al., 2016) . Not surprisingly, all these behavioral paradigms reduce chronic stress, a pathway we invoked repeatedly in this review as the likely common culprit of multi-hit etiology which manifests a disease susceptibility into a clinical neurodegenerative phenotype.
Conclusion
We highlighted the many questions and avenues for research to advance our understanding of early life programming of susceptibility for adult neurodegenerative diseases. Certain basic elements of this phenomenon came up repeatedly: chronic stress, neuroinflammation triggering microglial polarization and their connection to neurodegeneration. A recent review attempts a synthesis during adult life (Y. Z. Liu, Wang, & Jiang, 2017) , but no data seem to exist yet to extend this etiology to early life and thus more work is needed. Are chronic stress and neuroinflammation two sides of the same coin? Is this coin called "neuraging" or "immunosenescence"?
As we think about early life effects, we need to keep in mind that this is in fact a multigenerational phenomenon. It begs the question whether chronic stress and other powerful early life insults act as evolutionary pressures on the species development, expressed via neurodegenerative diseases, powerful modulators of social structures and factors limiting severely our productive age span. What distinguishes the centenarians that remain untouched from neurodegenerative conditions? The common denominator appears to be their subjective ability to handle stress (cf. this TEDx talk). We wish to close with an exciting big question: is perhaps the subjective processing of stimuli as "less or not stressful" a key to long life with reduced immunosenescence and hence delayed or no neurodegeneration? Is this phenotype influenced by early life experiences and inherited multigenerationally? Indeed, microglial senescence is discussed as a contributor to age-related neurodegeneration (Luo, Ding, & Chen, 2010; von Bernhardi, Eugenin-von Bernhardi, & Eugenin, 2015) . This then is amplified by the DoHAD component of senescence and "neuraging." Contributions of the telomere shortening on this dynamics remain to be elucidated (R. Wang et al., 2017) .
An important recent report in American Economic Review emphasizes that the phenomena of ELS and their chronic societal neglect are perpetuated through generations increasing inequality (Persson & Rossin-Slater, 2018) . It is cheaper to just pay the interest, but the long-term cost of the loan only grows exponentially, if we neglect the capital investment in the early life health and research. The fate of microglia in early life and subsequent risk for neurogenerative disease represent an important facet of this health care puzzle our generation is confronted with, more than ever before.
